|
Volumn 346, Issue , 2006, Pages 517-534
|
Pharmacogenetics: defining the genetic basis of drug action and inositol trisphosphate analysis.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
INOSITOL 1,4,5 TRISPHOSPHATE;
TRANQUILIZER;
ANIMAL;
ARTICLE;
BIPOLAR DISORDER;
DICTYOSTELIUM;
DISEASE MODEL;
DRUG EFFECT;
DRUG RESISTANCE;
DRUG SCREENING;
GENE DELETION;
GENE TARGETING;
GENETICS;
HUMAN;
PHARMACOGENETICS;
RESTRICTION MAPPING;
TRANSPOSON;
ANIMALS;
ANTIMANIC AGENTS;
BIPOLAR DISORDER;
DICTYOSTELIUM;
DISEASE MODELS, ANIMAL;
DNA TRANSPOSABLE ELEMENTS;
DRUG EVALUATION, PRECLINICAL;
DRUG RESISTANCE;
GENE DELETION;
GENE TARGETING;
HUMANS;
INOSITOL 1,4,5-TRISPHOSPHATE;
PHARMACOGENETICS;
RESTRICTION MAPPING;
MLCS;
MLOWN;
|
EID: 33747892281
PISSN: 10643745
EISSN: None
Source Type: Journal
DOI: 10.1385/1-59745-144-4:517 Document Type: Article |
Times cited : (6)
|
References (0)
|